CClinicalTrials.gg
Status unknownNCT041449467TKneeUpdated Mar 25, 2021

Identification of Early Changes in Patellar Tendinopathy Using Ultra-high Field Strength MRI

An observational study in Tendon Injuries, Tendinopathy and Patella; Tendinitis, sponsored by Bispebjerg Hospital. Status unknown at 1 site in Denmark. Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-03-25.

Sponsored by Bispebjerg Hospital · Observational

The sponsor has not verified this record recently (last verified Mar 2021), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
45
Ages
18 Years to 45 Years
Sex
All
01

Study summary

This project will investigate patellar tendon tissue (transmission electron microscopy of structure and protein analyses) coupled with magnetic resonance imaging (1.5T and 7T) from persons with i) chronic patellar tendinopathy (CT), ii) the earliest possible signs and symptoms of patellar tendinopathy (ET), and iii) symptom free controls (CTRL)(matched for age and physical activity/sports participation).

The investigators hypothesize that 7T MRI will be able to detect more subtle changes in early tendinopathy as compared to 3T MRI, thereby taking advantage of the increased spatial resolution that can be obtained in MRI with higher field strength. Further the investigator hypothesise that alterations in the tissue will be more pronounced in the CT group compared to ET and healthy controls.

Read the detailed description

Tendon tissue plays an essential role in transmitting contractile forces to bone to produce movement and is therefore uniquely designed to withstand considerable loads (up to \~8 times body weight) during human locomotion. Yet, repetitive use often results in overuse injuries such as tendinopathies, which is a common clinical condition characterized by pain during activity, localized tenderness upon palpation, swelling of the tendon and impaired performance. Tendinopathy is a sizeable problem in both elite and recreational athletes. In fact, the incidence of tendon injuries has been estimated to be as high as 30-50% of all sports injuries, and 50% of elite endurance runners, and 6% of sedentary people will at some point experience a tendon injury. Moreover, the symptoms and reduction in performance may be quite protracted and last for years. To date the ability to detect the early onset of the disease, and thus to prevent it from becoming chronic and debilitating, remains an enigma and the investigators wish to bridge this gap in knowledge by studying patellar tendon tissue samples coupled with magnetic resonance imaging (3T and 7T)

02

Conditions studied

  • Tendon Injuries
  • Tendinopathy
  • Patella; Tendinitis
03

In context

Tendinopathy

413 studies on the registry are indexed under Tendinopathy; 64 are open to participants now.

This study's planned enrollment of 45 is below the median of 67 across 52 observational studies indexed under Tendinopathy.

Browse Tendinopathy studies →

Lead sponsor

Bispebjerg Hospital is the lead sponsor of 281 studies on the registry; 29 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Sports active individuals

Inclusion criteria

Common for all groups

  • Sports active individuals.
  • Age [18-45] years old.
  • BMI [18.5-30]

ET - group

  • Symptom onset within 90 days at inclusion
  • Clinical signs of patellar tendinopathy.
  • Activity related pain in the patellar tendon.
  • Palpation pain in the proximal part of the patellar tendon.
  • At least one of the following three changes on the ultrasound scanning:

    • Thickening of the AP diameter on the symptomatic side.
    • Increased Power Doppler signal on the symptomatic side.
    • Hypoechogenic area corresponding to the symptomatic area of the tendon.

CT - group,

  • Symptom onset >90 days ago
  • Clinical signs of patellar tendinopathy.
  • Activity related pain in the patellar tendon.
  • Palpation pain in the proximal part of the patellar tendon.
  • At least one of the following three changes on the ultrasound scanning:

    • Thickening of the AP diameter on the symptomatic side.
    • Increased Power Doppler signal on the symptomatic side.
    • Hypoechogenic area corresponding to the symptomatic area of the tendon.

CTRL - group - Similar activity level as the two patient groups.

Exclusion criteria

Exclusion Criteria:

Common for all groups

  • Previous surgery in the knee on the ipsilateral side.
  • Previous corticosteroid injection in the patellar tendon on the ipsilateral side.
  • Smoking
  • Known arthritis
  • Known diabetes
  • Known hypercholesterolemia
  • Previous injections in the ipsilateral tendon.
  • MRI contraindications

    • Ferromagnetic objects
    • Pregnancy
    • Lactation

ET - group

  • Previous injuries in the patellar tendon on the ipsilateral side.
  • Started systematized treatment.

CTRL - group

  • Previous injuries in the patellar tendon on the ipsilateral side.
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
45 participants (estimated)
Patient registry
No
Biospecimen retention
Samples with dna

Groups and cohorts

  • Healthy control group (CTRL)

    Sports active individuals with no history of patellar tendinopathy.

  • Early tendinopathy group (ET)

    Sports active individuals with clinical signs of early tendinopathy and debut of symptoms within 90 days.

  • Chronic tendinopathy group (CT)

    Sports active individuals with clinical signs of tendinopathy and duration of symptoms \>90 days.

06

What researchers measure

Primary outcomes

  1. Cross sectional area (CSA) on Magnetic Resonance Imaging knee scans

    Magnetic Resonance Imaging of the knee, used to measure cross sectional area (cm\^2)

    Time frame: 0 months, observational cross sectional study.

  2. Decay times from Magnetic Resonance Imaging knee scans

    Magnetic Resonance Imaging of the knee used to calculate decay times (ms) in the tendon tissue.

    Time frame: 0 months, observational cross sectional study.

  3. Patellar tendon biopsies

    Tendon biopsies obtained with bard magnum instrument approximately 10 mg. Used for quantitative mRNA measures expressed as relative values to the expression of a housekeeping gene with stable expression (AU).

    Time frame: 0 months, observational cross sectional study.

Secondary outcomes

  1. International Physical Activity Questionnaire (IPAQ)

    IPAQ categorical scores (High, moderate or low activity level) will be reported, to characterise participants activity level

    Time frame: 0 months, observational cros sectional study.

  2. Body Mass Index

    BMI

    Time frame: 0 months, observational cross sectional study.

  3. Questionnaires - weekly activity level (time consumption)

    hours/week spend on leisure time activities loading the legs.

    Time frame: 0 months, observational cross sectional study.

  4. Questionnaires - Numerical Rating Scale (NRS) - Pain

    range 0-10, 10 being the highest possible pain level and 0 being no pain.

    Time frame: 0 months, observational cross sectional study.

  5. VISA-P

    Standardised score of functional capability, in patient with patellar tendinopathy. Total score will be reported; scale (0-100). 100=full functional capacity 0=poor functional capacity.

    Time frame: 0 months, observational cross sectional study.

07

Study locations

1 of 1 sites recruiting
  • Institute of Sports Medicine Copenhagen
    Copenhagen, NV 2400, Denmark
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 25, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04144946
Lead sponsor
Bispebjerg Hospital
Responsible party
Nikolaj Mølkjær Malmgaard-Clausen (Medical Doctor, PhD student, Bispebjerg Hospital) — Principal investigator
First posted
Oct 30, 2019
Start date
Oct 18, 2019
Primary completion
Oct 2021 (estimated)
Completion
Oct 2021 (estimated)
Last update
Mar 25, 2021

Study contacts

Nikolaj Malmgaard-Clausen, MD
Contact
nikolaj.moelkjaer.malmgaard-clausen@regionh.dk
+4538635069
Michael Kjær, Professor
principal investigator · Institute of Sports Medicine, Copenhagen

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion